WAVEFORM INTELLIGENCE
DEAD

Serial Number

98550900

Owner

EMx Biotech LLC

Attorney

Amit Kulkarni

Filing Date

May 14, 2024

Add to watchlist:

No watchlists yet
View on USPTO

WAVEFORM INTELLIGENCE Trademark

Serial Number: 98550900

WAVEFORM INTELLIGENCE is a trademark filed by EMx Biotech LLC on May 14, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

EMx Biotech LLC (2 trademarks)

1633 Waterston Ave., Apt. C
Austin, TX 78703

Entity Type: 16

Trademark Details

Filing Date

May 14, 2024

Registration Date

Not Registered

Goods & Services

Downloadable Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Downloadable Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Pressure measuring apparatus; Recorded Software as a Medical Device (SaMD) for diagnosing and treating abnormal vital signs; Recorded Software as a Medical Device (SaMD) for diagnosing abnormal vital signs; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), downloadable, for measuring and displaying the electrical signal produced by the heart; Software as a Medical Device (SaMD), downloadable, for the treatment of diabetes by monitoring glucose levels; Software as a Medical Device (SaMD), downloadable, for use as a medical instrument for vital sign monitoring; Software as a Medical Device (SaMD), downloadable, for use as electrocardiographs; Software as a Medical Device (SaMD), recorded, for diagnosing and treating abnormal vital signs; Software as a Medical Device (SaMD), recorded, for diagnosing abnormal vital signs; Software as a Medical Device (SaMD), recorded, for use as a medical instrument for vital sign monitoring

Blood pressure and diabetic diagnostic medical devices; Computerized medical recording and analysis apparatus for the diagnosis and treatment of arrhythmias; Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Diagnostic apparatus for medical purposes used in medical laboratories for testing vital signs; Manometers for medical purposes being arterial blood pressure measuring apparatus; Medical and surgical apparatus and instruments for use in vital sign monitoring procedures; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical apparatus and instruments for monitoring vital signs; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments for use in vital sign monitoring procedures; Medical apparatus and instruments relating to neurovegetative reactivity; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing suspected heart attacks; Medical apparatus for monitoring blood glucose levels; Medical apparatus for monitoring vital signs of patients; Medical apparatus for preventing or reversing heart failure; Medical apparatus for the treatment of respiratory conditions; Medical apparatus for use in treating abnormal vital signs; Medical apparatus, namely, fetal and maternal vital sign and physical distress monitors; Medical apparatus, namely, respiratory equipment and monitors therefor; Medical device used for the acquisition of physiological data for polysomnography; Medical device, namely, a device for improving cardiac performance through aortic flow therapy; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of recorded software for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices for treating congestive heart failure; Medical devices for use in diagnosing abnormal vital signs; Medical devices for use in treating abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs; Medical devices for use in treating or diagnosing abnormal vital signs with integrated recorded operating system software, sold as a unit; Medical devices, namely, myocardial ischemia scanning devices; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical devices, namely, pulse generators for vital sign monitoring; Medical diagnostic apparatus for testing vital signs; Medical diagnostic apparatus for testing vital signs incorporating recorded operating system software; Medical imaging apparatus for use in the field of vital sign monitoring; Medical imaging apparatus for use in the field of vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus for vital sign monitoring; Medical imaging apparatus for vital sign monitoring incorporating recorded operating system software; Medical imaging apparatus with embedded operating system software; Medical imaging devices for vital sign monitoring; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Surgical and medical apparatus and instruments for use in general surgery; Surgical and medical apparatus and instruments for use in vital sign monitoring during surgery; Ultrasound apparatus for medical purposes; Ultrasound apparatus for medical use; Arterial blood pressure measuring apparatus; Blood pressure measuring apparatus

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 15, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 15, 2025 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 29, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 29, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 29, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 24, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 24, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 24, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 24, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2024 NWOS
NEW APPLICATION ENTERED
May 15, 2024 NWAP